Zivo Bioscience (ZIVO, $7.47) was a top loser over the last three months, falling -1 to $7.47 per share. A.I.dvisor analyzed 894 stocks in the Biotechnology Industry for the 3-month period ending June 6, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.